NCT01286766 2024-12-27
Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric Adenocarcinoma
Yonsei University
Phase 2 Completed
Clinical Trials
39 trialsNCT04999332 2023-11-15
LOTS
National Cheng-Kung University Hospital
Phase 2 Unknown
NCT02191566 2022-12-08
SOHUG
Kangbuk Samsung Hospital
Phase 2 Terminated
NCT00429858 2020-09-18
Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
University of California, San Francisco
Phase 2 Terminated
NCT00915382 2020-01-07
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
Asan Medical Center
Phase 3 Completed
NCT01283204 2019-01-29
Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer
Yonsei University
Phase 2 Completed
NCT01430052 2017-11-21
Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer
Osaka Medical Center for Cancer and Cardiovascular Diseases
Phase 2 Completed
NCT01693419 2017-08-23
S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Hallym University Medical Center
Phase 2 Completed
NCT01693432 2017-08-23
Docetaxel and S-1 for Advanced Esophageal Cancer
Hallym University Medical Center
Phase 2 Unknown
NCT02527785 2017-08-23
Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer
Hallym University Medical Center
Phase 2 Completed
NCT02870153 2016-08-19
SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer
The First People's Hospital of Changzhou
Phase 2 Unknown
NCT00660894 2016-08-03
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Phase 3 Completed
NCT00216034 2016-06-07
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK
Hokuriku-Kinki Immunochemotherapy Study Group
Phase 3 Completed
NCT01693445 2016-02-19
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
Hallym University Medical Center
Phase 1 Completed
NCT01671449 2015-11-30
SOPP
Asan Medical Center
Phase 3 Completed
NCT01128998 2015-10-19
Sorafenib Plus S-1 in Advanced Solid Tumors
National Health Research Institutes, Taiwan
Phase 1 Completed
NCT00438100 2015-05-29
Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer
Japan Breast Cancer Research Network
Phase 2 Completed
NCT01679340 2015-05-19
A Phaseâ…¡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery
Peking University
Phase 2 Unknown
NCT01269216 2015-01-28
A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer
Yonsei University
Phase 2 Completed
NCT02146703 2014-05-26
Gemcitabine and S-1 for Advanced Biliary Tract Cancer
Hallym University Medical Center
Phase 2 Completed
NCT00527930 2013-10-10
TORCH
Seoul National University Hospital
Phase 2 Completed
NCT01269255 2013-06-04
A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric Cancer
Yonsei University
Phase 1 Completed
NCT01824004 2013-04-04
Postoperative Chemoradiotherapy With S-1 in Gastric Cancer
Chonnam National University Hospital
Phase 2 Completed
NCT00677144 2012-10-05
Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer
Hallym University Medical Center
Phase 2 Completed
NCT01645748 2012-07-20
TPSHNSCC
Chonnam National University Hospital
Phase 2 Completed
NCT01608646 2012-05-31
Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer
Xijing Hospital
Phase 2 Unknown
NCT00687843 2012-03-22
TMOG-GC01
Tokyo Metropolitan Oncology Group
Phase 3 Unknown
NCT01533324 2012-02-15
S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)
Second Military Medical University
Phase 2 Unknown
NCT01131689 2012-02-02
Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma
Samsung Medical Center
Phase 1 Completed
NCT00287768 2011-06-28
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
Japan Clinical Cancer Research Organization
Phase 3 Completed
NCT00514163 2011-06-28
GEM vs GEM+TS-1 for Advanced Pancreatic Cancer
Japan Clinical Cancer Research Organization
Phase 2 Completed
NCT00639327 2011-06-28
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
Japan Clinical Cancer Research Organization
Phase 2/3 Completed
NCT01096745 2011-06-23
Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer
Gyeongsang National University Hospital
Phase 2 Terminated
NCT00209729 2010-05-26
Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.
Hokkaido Gastrointestinal Cancer Study Group
Phase 1/2 Suspended
NCT00961077 2009-08-18
Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer
Soonchunhyang University Hospital
Phase 2 Unknown
NCT00531245 2009-07-02
A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal Cancer
Samsung Medical Center
Phase 1/2 Completed
NCT00209651 2007-11-01
Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group
Phase 2 Unknown
NCT00316745 2007-11-01
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group
Phase 3 Suspended
NCT00436423 2007-11-01
A Phase â…¡ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer
Korea University Anam Hospital
Phase 2 Completed